Nobel Winner's Team Succeeds in Mass-Producing Tregs, Aims to Tackle Autoimmune Diseases with New Treatment

sakaguchi
A research team led by Nobel Prize winner Shimon Sakaguchi, a specially appointed professor at the University of Osaka, has developed technology to mass-produce regulatory T cells (Tregs), which can be used to treat immune diseases, the team has announced.

New contents